Nuclear Medicine Unplugged Transforming Workflow for Nuclear Medicine Bringing Molecular Imaging to the Point of Care
Nuclear Medicine Unplugged Transforming Workflow for Nuclear Medicine Bringing Molecular Imaging to the Point of Care
Serac Imaging Systems has developed Seracam®, a revolutionary and exceptionally versatile high resolution gamma-optical camera, aiming to bring nuclear imaging to the patient bedside
Seracam leverages technology designed for NASA space observatories to match or exceed the performance of the current class of systems with greater ease of use for small organ imaging procedures. Seracam has been designed from the outset for its practical application, with its compact design and intuitive operating system enabling imaging at the point of care. This will ease pressure on complex SPECT/ CT cameras by providing an efficient and cost-effective alternative for conducting many routine, simple, but often time-consuming procedures.
This technology has the potential to improve patient access to care, improve workflow in the nuclear medicine department, and reduce healthcare system costs.
Seracam is currently being tested at a number of clinical sites ahead of regulatory submission.
Seracam is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities.
Unique Hybrid gamma-optical camera
The automatic overlay of the gamma and optical images, with matched fields of view and alignment maintained at any imaging angle or distance, gives clinicians precision imaging.
Such enhanced imaging technology has the potential to help clinicians make better, more informed and more timely treatment decisions. The optical overlay also enhances patient understanding of the images.
Point-of-Care Imaging
Seracam is designed to allow imaging to be routinely taken from the nuclear medicine department to the patient, wherever they may be – the outpatient clinic, hospital ward, physician’s office, the intensive care unit, or operating theatre.
Currently, this imaging is largely restricted to patients who can be referred to the nuclear medicine department of a hospital where large, expensive, heavy and complex cameras are sited in dedicated rooms.
Seracam® Features
Simple and intuitive
Unique hybrid gamma-optical imaging enhances utility and usability
Highly versatile, easily relocated for point-of-care imaging
Small and patient friendly
Flexible head for multiple scanning applications
Affordable
Same-day installation, minimal service requirements and no downtime
Our Technology
Seracam®: Game-changing gamma imaging made easy
Like all gamma cameras, Seracam is used to form images revealing the distribution of a radiopharmaceutical that has been administered to a patient in order to help in the diagnosis or monitoring of disease.
Seracam® uses a microcolumnar CsI(Tl) crystal scintillator to convert gamma photons to optical photons that are detected by a semi-conductor.
Fresh and Novel Design Approach
- Designed from the outset for ease of use, compact design, and truly mobile for imaging at the point-of-care
- Unconstrained by pre-conceived ideas from traditional nuclear medicine imaging systems
- Incorporates cutting-edge technologies from other industries including technology designed for NASA space observatories to deliver equal or better performance than the current standard of care
Investment Opportunities
Serac Imaging Systems is a privately owned, clinical stage medical imaging company. We are always ready to talk to investors who match our ambitions and can help us excel. If you would like to discuss investment opportunities, please do get in touch.
Meet the Team
Discover more about the team behind Serac Imaging Systems.
Latest News
Innovate UK grant awarded to develop Seracam® for image guided surgical oncology
London, UK, 26 March 2024. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the
Company”), the medtech company developing Seracam®, a portable hybrid gamma-optical camera
for medical imaging, and Loughborough University announce that a grant has been awarded by
Innovate UK, the UK’s innovation agency, to Loughborough University to co-fund the development of
the camera for image guided surgery.
Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam®
London, UK and New York, USA, 6 September 2023, Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medtech company developing Seracam®, a portable hybrid gamma-optical camera for medical imaging, and the Icahn School of Medicine at Mount Sinai, a ground-breaking leader in medical education, today announce the start of clinical testing using the Seracam® camera.
James Kaufman appointed as Chief Commercial Officer
London, UK, 20 June 2023. Serac Imaging Systems Limited (“Serac Imaging Systems” or “the Company”), the medical technology company developing Seracam®, a portable hybrid gamma-optical camera for medical imaging, today announces the appointment of James Kaufman as Chief Commercial Officer. James brings almost thirty years’ experience in the global healthcare and molecular imaging industry and will be responsible for leading on the commercialisation of Seracam®, reporting to Chief Executive, Mark Rosser.
